Cargando…
Identification of FGF13 as a Potential Biomarker and Target for Diagnosis of Impaired Glucose Tolerance
Early identification of pre-diabetes provides an opportunity for intervention and treatment to delay its progression to type 2 diabetes mellitus (T2DM). We aimed to identify the biomarkers of impaired glucose tolerance (IGT) through bioinformatics analysis. The GSE76896 dataset, including non-diabet...
Autores principales: | Chen, Qi, Li, Fangyu, Gao, Yuanyuan, Yang, Fengying, Yuan, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867186/ https://www.ncbi.nlm.nih.gov/pubmed/36675322 http://dx.doi.org/10.3390/ijms24021807 |
Ejemplares similares
-
FGF23, Biomarker or Target?
por: Rodelo-Haad, Cristian, et al.
Publicado: (2019) -
Prevalence, Diagnosis, and Treatment of Impaired Fasting Glucose and Impaired Glucose Tolerance in Nondiabetic U.S. Adults
por: Karve, Amrita, et al.
Publicado: (2010) -
Analysis of Functional Promoter of Camel FGF21 Gene and Identification of Small Compounds Targeting FGF21 Protein
por: Yong, Fang, et al.
Publicado: (2023) -
Adipokine Pattern in Subjects with Impaired Fasting Glucose and Impaired Glucose Tolerance in Comparison to Normal Glucose Tolerance and Diabetes
por: Tönjes, Anke, et al.
Publicado: (2010) -
FoxO1 suppresses Fgf21 during hepatic insulin resistance to impair peripheral glucose utilization and acute cold tolerance
por: Stöhr, Oliver, et al.
Publicado: (2021)